Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-06 5:50 pm Purchase | 2026-07-30 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | RA Capital Management, L.P. | 18,288,220 5.800% | 18,288,220![]() (New Position) | Filing History |
| 2026-08-03 4:37 pm Purchase | 2026-07-27 | 13G | Scribe Therapeutics Inc. SCTX | RA Capital Management, L.P. | 1,802,178 9.600% | 1,802,178![]() (New Position) | Filing History |
| 2026-08-03 4:36 pm Purchase | 2026-07-27 | 13G | CAPRICOR THERAPEUTICS INC CAPR | RA Capital Management, L.P. | 3,014,183 5.200% | 3,014,183![]() (New Position) | Filing History |
| 2026-07-31 4:33 pm Sale | 2026-07-29 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | RA Capital Management, L.P. | 14,653,994 9.900% | -10,346,006![]() (-41.38%) | Filing History |
| 2026-07-23 9:23 pm Purchase | 2026-07-22 | 13D | ARTIVA BIOTHERAPEUTICS INC ARTV | RA Capital Management, L.P. | 18,415,956 37.900% | 604,333![]() (+3.39%) | Filing History |
| 2026-07-22 5:34 pm Purchase | 2026-07-20 | 13D | PERCEPTIVE CAP SOLUTIONS CORP PCSC | RA Capital Management, L.P. | 15,367,270 14.300% | 14,617,270![]() (+1948.97%) | Filing History |
| 2026-07-21 4:55 pm Purchase | 2026-07-16 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,937,855 19.900% | 41,336![]() (+0.32%) | Filing History |
| 2026-07-20 4:16 pm Purchase | 2026-07-13 | 13G | AGENUS INC PAR $0.01 AGEN | RA Capital Management, L.P. | 4,344,772 9.900% | 4,344,772![]() (New Position) | Filing History |
| 2026-07-17 5:52 pm Purchase | 2026-07-10 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | RA Capital Management, L.P. | 25,000,000 15.900% | 25,000,000![]() (New Position) | Filing History |
| 2026-07-07 4:41 pm Purchase | 2026-07-02 | 13D | CLIMB BIO, INC. CLYM | RA Capital Management, L.P. | 23,249,186 33.000% | 617,785![]() (+2.73%) | Filing History |
| 2026-07-02 8:26 pm Sale | 2026-06-30 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 1,985,541 4.100% | -930,201![]() (-31.90%) | Filing History |
| 2026-06-26 5:39 pm Sale | 2026-06-24 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 2,915,742 6.000% | -738,565![]() (-20.21%) | Filing History |
| 2026-06-24 6:49 pm Purchase | 2026-06-22 | 13D | SOLID BIOSCIENCES INC SLDB | RA Capital Management, L.P. | 12,036,126 11.900% | 2,722,370![]() (+29.23%) | Filing History |
| 2026-06-22 7:02 pm Sale | 2026-06-17 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 3,654,307 7.500% | -1,484,396![]() (-28.89%) | Filing History |
| 2026-06-18 4:09 pm Purchase | 2026-06-11 | 13D | PARABILIS MEDICINES INC PBLS | RA Capital Management, L.P. | 28,933,371 23.800% | 28,933,371![]() (New Position) | Filing History |
| 2026-06-15 8:16 pm Sale | 2026-06-11 | 13D | WEREWOLF THERAPEUTICS INC HOWL | RA Capital Management, L.P. | 5,138,703 10.600% | -977,437![]() (-15.98%) | Filing History |
| 2026-06-15 7:37 pm Purchase | 2026-06-11 | 13D | ARTIVA BIOTHERAPEUTICS INC ARTV | RA Capital Management, L.P. | 17,811,623 36.600% | 1,434,155![]() (+8.76%) | Filing History |
| 2026-06-04 5:01 pm Purchase | 2026-05-28 | 13G | Q32 BIO INC QTTB | RA Capital Management, L.P. | 2,332,457 9.800% | 2,332,457![]() (New Position) | Filing History |
| 2026-06-03 4:45 pm Purchase | 2026-05-27 | 13G | EDITAS MEDICINE INC EDIT | RA Capital Management, L.P. | 8,889,000 5.800% | 8,889,000![]() (New Position) | Filing History |
| 2026-05-21 9:12 pm Purchase | 2026-05-14 | 13G | SANA BIOTECHNOLOGY INC SANA | RA Capital Management, L.P. | 18,750,000 6.300% | 18,750,000![]() (New Position) | Filing History |

